275 related articles for article (PubMed ID: 23316315)
1. Type 2 diabetes restricts multipotency of mesenchymal stem cells and impairs their capacity to augment postischemic neovascularization in db/db mice.
Yan J; Tie G; Wang S; Messina KE; DiDato S; Guo S; Messina LM
J Am Heart Assoc; 2012 Dec; 1(6):e002238. PubMed ID: 23316315
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes impairs the ability of skeletal muscle pericytes to augment postischemic neovascularization in db/db mice.
Hayes KL; Messina LM; Schwartz LM; Yan J; Burnside AS; Witkowski S
Am J Physiol Cell Physiol; 2018 May; 314(5):C534-C544. PubMed ID: 29351404
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy.
Yan J; Tie G; Xu TY; Cecchini K; Messina LM
Stem Cell Rev Rep; 2013 Jun; 9(3):360-72. PubMed ID: 23475434
[TBL] [Abstract][Full Text] [Related]
4. Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice.
Amin AH; Abd Elmageed ZY; Nair D; Partyka MI; Kadowitz PJ; Belmadani S; Matrougui K
Lab Invest; 2010 Jul; 90(7):985-96. PubMed ID: 20440273
[TBL] [Abstract][Full Text] [Related]
5. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.
Yan J; Tie G; Park B; Yan Y; Nowicki PT; Messina LM
J Vasc Surg; 2009 Dec; 50(6):1412-22. PubMed ID: 19837544
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody.
Liew A; Baustian C; Thomas D; Vaughan E; Sanz-Nogués C; Creane M; Chen X; Alagesan S; Owens P; Horan J; Dockery P; Griffin MD; Duffy A; O'Brien T
Cell Transplant; 2018 Aug; 27(8):1210-1221. PubMed ID: 30016879
[TBL] [Abstract][Full Text] [Related]
7. Perivascular delivery of encapsulated mesenchymal stem cells improves postischemic angiogenesis via paracrine activation of VEGF-A.
Katare R; Riu F; Rowlinson J; Lewis A; Holden R; Meloni M; Reni C; Wallrapp C; Emanueli C; Madeddu P
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1872-80. PubMed ID: 23766261
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow mesenchymal stem cells overexpressing human basic fibroblast growth factor increase vasculogenesis in ischemic rats.
Zhang JC; Zheng GF; Wu L; Ou Yang LY; Li WX
Braz J Med Biol Res; 2014 Oct; 47(10):886-94. PubMed ID: 25118628
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy.
Nammian P; Asadi-Yousefabad SL; Daneshi S; Sheikhha MH; Tabei SMB; Razban V
Stem Cell Res Ther; 2021 Jan; 12(1):58. PubMed ID: 33436054
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
[TBL] [Abstract][Full Text] [Related]
11.
Chen T; Ye B; Tan J; Yang H; He F; Khalil RA
Biochem Pharmacol; 2021 Aug; 190():114530. PubMed ID: 33891966
[TBL] [Abstract][Full Text] [Related]
12. Role of nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia.
Urao N; Inomata H; Razvi M; Kim HW; Wary K; McKinney R; Fukai T; Ushio-Fukai M
Circ Res; 2008 Jul; 103(2):212-20. PubMed ID: 18583711
[TBL] [Abstract][Full Text] [Related]
13. Type-2 diabetic Lepr(db/db) mice show a defective microvascular phenotype under basal conditions and an impaired response to angiogenesis gene therapy in the setting of limb ischemia.
Emanueli C; Caporali A; Krankel N; Cristofaro B; Van Linthout S; Madeddu P
Front Biosci; 2007 Jan; 12():2003-12. PubMed ID: 17127438
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan protects mesenchymal stem cells against oxidative stress and enhances vascular regeneration in a murine hindlimb ischemia model.
Han YS; Lee JH; Jung JS; Noh H; Baek MJ; Ryu JM; Yoon YM; Han HJ; Lee SH
Int J Cardiol; 2015 Nov; 198():187-95. PubMed ID: 26163916
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation.
Li Y; Zhang D; Zhang Y; He G; Zhang F
J Biomed Sci; 2010 Sep; 17(1):75. PubMed ID: 20846454
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model.
Yao Z; Liu H; Yang M; Bai Y; Zhang B; Wang C; Yan Z; Niu G; Zou Y; Li Y
Stem Cell Res Ther; 2020 Jun; 11(1):221. PubMed ID: 32513272
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Gremlin1 in Mesenchymal Stem Cells Improves Hindlimb Ischemia in Mice by Enhancing Cell Survival.
Xiang Q; Hong D; Liao Y; Cao Y; Liu M; Pang J; Zhou J; Wang G; Yang R; Wang M; Xiang AP
J Cell Physiol; 2017 May; 232(5):996-1007. PubMed ID: 27579673
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen regulates mesenchymal stem cell-mediated tissue repair after ischemia through Cyr61 activation.
Duan H; He Z; Lin M; Wang Y; Yang F; Mitteer RA; Kim HJ; Yeo E; Han H; Qin L; Fan Y; Gong Y
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759492
[TBL] [Abstract][Full Text] [Related]
19. Diabetic Mesenchymal Stem Cells Are Ineffective for Improving Limb Ischemia Due to Their Impaired Angiogenic Capability.
Kim H; Han JW; Lee JY; Choi YJ; Sohn YD; Song M; Yoon YS
Cell Transplant; 2015; 24(8):1571-84. PubMed ID: 25008576
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.
Madonna R; Taylor DA; Geng YJ; De Caterina R; Shelat H; Perin EC; Willerson JT
Circ Res; 2013 Sep; 113(7):902-14. PubMed ID: 23780385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
